Skip to main content
Trending
Zaporizhzhia plantPlanetary defenseSouth korea economyCircuit splitsWi-fi 8 hardwarePhotosynthesis limitsMarket strategyHvac codeAssessment reformProduction economicsNetwork theoryNetwork strategyMetabolic scienceSpace-based sigintManagerial shiftAviation safetyBrake architectureData structuresOffice softwareTitle riskExercise physiologyChart geometryCooking methodsLihtc paradoxNetwork architectureIndex mechanicsBiodiversity lossSelf-healing concreteCinema technologyCritical minerals

Medical Research

All HealthNutrition & DietSupplementsMental HealthSleepLongevityMedicineMedications & TreatmentsConditions & DiseasesHormones & EndocrinologySkincareDental HealthFamily HealthChildren's HealthMen's HealthWomen's HealthAging & GeroscienceBiohackingAlternative MedicinePublic HealthMedical ResearchPreventive WellnessHealthy Habits
Explainer

Clinical Study Finds Semaglutide Slows Biological Aging Markers, Suggesting First Longevity Effect

6 sources · 53d ago

Explainer

FDA Approves First Solid Tumor Therapy Requiring Circulating Tumor DNA Test for Adjuvant Treatment Selection

7 sources · 55d ago

Explainer

Landmark 7-Year Trial Finds Non-Surgical Heart Valve Replacement Matches Open-Heart Surgery Durability

4 sources · 55d ago

More in Medical Research

ExplainerProstate Cancer

Landmark Trial: Perioperative Apalutamide Improves Metastasis-Free Survival in Localized High-Risk Prostate Cancer

Clinical Investigators 45%Surgical Urologists 35%Pharmaceutical Developers 20%

5 sources · 56d ago

ExplainerOncology Breakthrough

Landmark Trial Cracks 'Undruggable' KRAS Target, Delivering Unprecedented Survival Advantage in Pancreatic Cancer

Targeted Therapy Advocates 45%Structural Biologists 30%Access & Policy Watchdogs 25%

7 sources · 57d ago

ExplainerMicrobial Oncology

Landmark Research: Single Dose of Amphibian-Derived Bacterium Eliminates Colorectal Tumors in Mice

Microbiome Researchers 40%Clinical Oncologists 35%Immunologists 25%

3 sources · 59d ago

Research BriefNeuroendocrinology

FDA Approves First Therapy for Acquired Hypothalamic Obesity Following Landmark Phase 3 Trial

Endocrinology Researchers 40%Patient Advocacy Groups 35%Healthcare Regulators 25%

3 sources · 60d ago

Research BriefMetabolic Disease

Landmark Phase 3 Trial: New Oral GLP-1 Pill Orforglipron Outperforms Semaglutide for Weight Loss and Diabetes Control

Metabolic Disease Specialists 40%Pharmaceutical Analysts 35%Clinical Cautious Voices 25%

4 sources · 61d ago

Research BriefADHD Innovation

First-in-Class NDSRI Centanafadine Poised to Reshape ADHD Treatment for All Ages

Clinical Psychiatrists 40%Neuropharmacology Researchers 30%Patient Advocates 30%

6 sources · 62d ago

ExplainerOncology Breakthrough

Landmark Immunotherapy Trial Achieves 33% Three-Year Survival in Previously Untreatable MSS Colorectal Cancer

Clinical Oncologists 40%Immunology Researchers 35%Patient Advocates & Ethicists 25%

4 sources · 63d ago

ExplainerOrexin Agonists

First-in-Class Orexin Agonist Oveporexton Shows Significant Improvement in Wakefulness for Narcolepsy Type 1 in Landmark Phase 3 Trials

Sleep Medicine Researchers 41%Patients & Advocacy Groups 35%Industry Analysts 24%

4 sources · 63d ago

Explore more topics

News & PoliticsWorldBusinessFinanceTechnologyArtificial IntelligenceScienceEnergy